The final program of the series, "FCPA and the Pharmaceutical Industry," focused on implications of the Foreign Corrupt Practices Act in the pharmaceutical industry.
- Overview of the FCPA and the 2010 U.K. Bribery Act
- Enforcement trends and the pharmaceutical industry
- Compliance programs and third-party due diligence
- Responding to an allegation
Presenters:View a recording of this webinar.